PROCEPT BioRobotics Corporation
NASDAQ:PRCT
53.04 (USD) • At close May 13, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 333.725 | 257.222 | 221.859 | 304.32 | 100.13 | 42.021 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 333.725 | 257.222 | 221.859 | 304.32 | 100.13 | 42.021 |
| Net Receivables
| 83.496 | 48.376 | 15.272 | 4.464 | 1.549 | 1.099 |
| Inventory
| 56.168 | 39.756 | 28.543 | 13.147 | 7.477 | 6.686 |
| Other Current Assets
| 8.453 | 5.213 | 6.952 | 6.828 | 1.1 | 0.93 |
| Total Current Assets
| 481.842 | 350.567 | 272.626 | 326.173 | 110.256 | 50.736 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 45.65 | 48.989 | 32.137 | 8.324 | 12.915 | 8.273 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0.932 | 1.204 | 1.477 | 1.75 | 2.023 | 2.295 |
| Goodwill and Intangible Assets
| 0.932 | 1.204 | 1.477 | 1.75 | 2.023 | 2.295 |
| Long Term Investments
| 0 | 0 | 3.038 | 0.777 | 0.777 | 0.691 |
| Tax Assets
| 0 | 0 | -3.038 | -0.777 | -0.777 | -0.691 |
| Other Non-Current Assets
| 5.593 | 3.957 | 3.089 | 0.777 | 0.777 | 0.691 |
| Total Non-Current Assets
| 52.175 | 54.15 | 36.703 | 10.851 | 15.715 | 11.259 |
| Total Assets
| 534.017 | 404.717 | 309.329 | 337.024 | 125.971 | 61.995 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 10.032 | 13.499 | 9.391 | 2.029 | 1.24 | 1.444 |
| Short Term Debt
| 1.91 | 3.408 | 2.129 | 4.21 | 6.259 | 0 |
| Tax Payables
| 2.068 | 1.725 | 0.829 | 0.515 | 0.302 | 0.09 |
| Deferred Revenue
| 9.565 | 5.656 | 2.855 | 1.025 | 0.233 | 0.106 |
| Other Current Liabilities
| 29.558 | 23.364 | 20.086 | 8.463 | 6.492 | 5.15 |
| Total Current Liabilities
| 53.133 | 45.927 | 35.29 | 16.241 | 14.526 | 6.79 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 78.34 | 77.521 | 75.188 | 51.995 | 48.503 | 23.224 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0.324 | 0.517 | 1.779 | 1.696 | 245.836 | 175.818 |
| Total Non-Current Liabilities
| 78.664 | 78.038 | 76.967 | 53.691 | 294.339 | 199.042 |
| Total Liabilities
| 131.797 | 123.965 | 112.257 | 69.932 | 308.865 | 205.832 |
| Equity: | ||||||
| Preferred Stock
| 0 | 0 | 0 | 337.024 | 243.854 | 173.068 |
| Common Stock
| 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings
| -545.985 | -454.572 | -348.675 | -261.521 | -201.668 | -148.649 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 0.084 | -0.006 | -0.053 | -0.014 | 0.004 |
| Other Total Stockholders Equity
| 948.205 | 735.24 | 545.753 | 528.666 | -225.066 | -168.26 |
| Total Shareholders Equity
| 402.22 | 280.752 | 197.072 | 267.092 | -182.894 | -143.837 |
| Total Equity
| 402.22 | 280.752 | 197.072 | 267.092 | -182.894 | -143.837 |
| Total Liabilities & Shareholders Equity
| 534.017 | 404.717 | 309.329 | 337.024 | 125.971 | 61.995 |